Clinical Trial Update: Dexlansoprazole to Treat Laryngopharyngeal Reflux and Lingual Tonsil Hypertrophy [Phase 4]

View source ↗

Summary

Dexlansoprazole is being studied in a Phase 4 trial to treat laryngopharyngeal reflux and lingual tonsil hypertrophy, with the trial status not reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Laryngopharyngeal Reflux
• Lingual Tonsil Hypertrophy

Drugs mentioned

• Dexilant (dexlansoprazole)

Snippet

Sponsor: Advanced Center for Specialty Care | Conditions: Laryngopharyngeal Reflux, Hypertrophy of Lingual Tonsil | Phase 4 | Status: UNKNOWN